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Alternative splicing (AS) plays a critical role in cell
fate transitions, development, and disease. Recent
studies have shown that AS also influences pluripo-
tency and somatic cell reprogramming. We profiled
transcriptome-wide AS changes that occur during
reprogramming of fibroblasts to pluripotency. This
analysis revealed distinct phases of AS, including a
splicing program that is unique to transgene-inde-
pendent induced pluripotent stem cells (iPSCs).
Changes in the expression of AS factors Zcchc24,
Esrp1, Mbnl1/2, and Rbm47 were demonstrated to
contribute to phase-specific AS. RNA-binding motif
enrichment analysis near alternatively spliced exons
provided further insight into the combinatorial regu-
lation of AS during reprogramming by different
RNA-binding proteins. Ectopic expression of Esrp1
enhanced reprogramming, in part by modulating
the AS of the epithelial specific transcription factor
Grhl1. These data represent a comprehensive tem-
poral analysis of the dynamic regulation of AS during
the acquisition of pluripotency.
INTRODUCTION
Alternative splicing (AS) is a versatile post-transcriptional mech-
anism that expands protein diversity required for numerous cell
fate transitions during development (Kalsotra and Cooper,
2011). In addition, alterations in AS patterns can lead to disease,
in many cases through dysregulation of key splicing regula-
tors (Cieply and Carstens, 2015). The regulation of AS involves
the assembly of both ubiquitous and cell-type-specific splicing
factors on RNA cis elements within or flanking regulated exonsThis is an open access article under the CC BY-Nthat can influence splicing positively or negatively (Chen and
Manley, 2009). Discerning how different splicing factors collabo-
rate to regulate key programs of AS remains a challenge but one
that can now be addressed using new genomic technologies.
The discovery that exogenous factors can reprogram so-
matic cells into induced pluripotent stem cells (iPSCs) has
opened up new fields of investigation that hold great promise
for new therapeutic applications (Lengner, 2010). Only recently
have roles for AS in pluripotency and reprogramming begun to
emerge, including the identification of roles for several splicing
regulators such as muscleblind-like splicing factors Mbnl1/2,
RBFOX2, Srsf3, and U2af1 (Gabut et al., 2011; Han et al.,
2013; Ohta et al., 2013; Salomonis et al., 2010; Venables
et al., 2013; Wu et al., 2010; Yeo et al., 2009). However, it is
likely that additional splicing regulators play a role during the
acquisition of pluripotency. A temporal analysis of transcrip-
tional dynamics during reprogramming of mouse embryonic
fibroblasts (MEFs) to iPSCs revealed that it is a multistep pro-
cess with distinct temporal phases, but AS was not assessed
(Samavarchi-Tehrani et al., 2010). It is therefore essential to
define the AS programs that accompany these transitional
phases and to identify splicing factors driving these dynamic
changes. Interestingly, an early phase of reprogramming from
MEFs to iPSCs is characterized by a mesenchymal-to-epithelial
transition (MET), which includes activation of the epithelial
splicing regulatory proteins 1 and 2 (Esrp1 and Esrp2), suggest-
ing that they may promote splicing changes at this critical
phase of reprogramming (Li et al., 2010; Samavarchi-Tehrani
et al., 2010).
We conducted a comprehensive temporal analysis of AS
during reprogramming using RNA sequencing (RNA-seq). This
revealed temporally dynamic and complex patterns of AS. By
correlating AS patterns with differential expression of a broad
panel of RNA-binding proteins (RBPs) and known splicing
factors, we were able to identify several examples of splicing
regulators that influence AS during reprogramming. EctopicCell Reports 15, 247–255, April 12, 2016 ª2016 The Authors 247
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
expression of Esrp1 substantially enhanced reprogramming effi-
ciency, in part through a splicing switch in the epithelial-specific
transcription factorGrhl1. These data highlight the importance of
regulated AS during cell fate transitions.
RESULTS
Comprehensive Temporal Analysis of Dynamic Changes
in Splicing during Somatic Cell Reprogramming
In order to profile AS during induction of pluripotency (using the
Yamanaka factors Oct4, Klf4, Sox2, and cMyc or OKSM), we
used MEFs from mice harboring a doxycycline (Dox)-inducible
polycistronic OKSM cassette (Stadtfeld et al., 2010). MEFs iso-
lated from these mice can be efficiently reprogrammed with
Dox, and using this induced pluripotency model, we conducted
a time course analysis of AS during reprogramming including
the isolation of three stable transgene-independent iPSC clones.
The iPSC clones expressed Nanog at levels similar to embryonic
stem cells (ESCs) and displayed an ESC-like morphology (Fig-
ures S1A and S1B). At each time point following Dox induction,
RNA was isolated from Ssea1-positive cells using magnetic acti-
vated cell sorting (MACS) in order to enrich for cells at an interme-
diate stage of reprogramming and exclude cells that will never
enter the pluripotent state (Brambrink et al., 2008). RNA from
triplicate samples was subjected to 101 base pair paired-end
sequencing. AS analysiswas conducted using replicatemultivar-
iate analysis of transcript splicing (rMATS) (Shen et al., 2014).
Whereas this analysis identified changes in cassette exons
(also referred to as skipped exons [SEs]), alternative 30 and 50
splice sites, retained introns, aswell asmutually exclusive exons,
we subsequently focused primarily on cassette exons. Our anal-
ysis revealed substantial changes in AS at each time point
following OKSM induction, revealing distinct temporal patterns
of AS during reprogramming (Figure 1A; Table S1). To further
delineate these patterns, we conducted an unbiased temporal
cluster analysis of all differentially spliced exons. Briefly, we per-
formed a co-splicing network analysis of differentially regulated
alternative exons during the time course, used a permutation-
based procedure to assess the significance of correlation be-
tween pairs of exons, and then partitioned the network with
appropriate correlation threshold to identify clusters of exons
corresponding todistinct temporal splicingpatterns. Thisdefined
18 clusters corresponding to distinct patterns of AS changes
across the timecourse (Figures 1Aand1B; TableS2). These clus-
ters included, for example, groups of exons with increased inclu-
sion or skipping in a graded manner (clusters 1 and 2), those that
change very early (clusters 3 and 8), and thosewith themost-pro-
nounced changes in splicing from day 20 to transgene-indepen-
dent iPSC clones (clusters 4 and 5). For several of these clusters,
we used RT-PCR to validate these distinct patterns of splicing
changes and determine quantitatively the values for exon inclu-
sion, or percent spliced in (PSI) at each time point (Figure 1C).
The Regulation of AS during Reprogramming Involves
Complex and Dynamic Combinatorial Contributions by
Numerous Splicing Factors
The temporal patterns of splicing changes suggested coordi-
nated regulation by different splicing factors at defined stages248 Cell Reports 15, 247–255, April 12, 2016of the process. We used the RNA-seq data to evaluate total
gene expression changes of all mouse genes at all stages across
the time course (Table S3). Then, to identify candidate regulators
of splicing during reprogramming, we conducted a temporal
cluster analysis using total gene expression levels for a list of
226 genes encoding RBPs with known or inferred functions in
splicing regulation. From this list, we identified 95 RBPs as
candidate regulators of AS during reprogramming using three
criteria: (1) expressed in at least one of the seven time points
(average fragments per kilobase of transcript per million mapped
reads [FPKM] > 5.0); (2) significant change in FPKM values
across the seven time points (ANOVA p < 0.01); and (3) at least
2-fold change in FPKM values between the two time points
with the highest and lowest average expression levels. These
analyses separated the 95 RBPs into nine distinct clusters
(Figure 2A; Table S2). In addition to defining clusters of RBPs
with similar temporal patterns of expression, we also conducted
a Jackknife version Pearson correlation coefficient between the
expression values of the 95 RBPs and the PSI values for all regu-
lated exons that changed across the time course (Table S2).
The genome-wide analysis of AS and RBP expression
changes during the reprogramming time course suggested
that the unique temporal patters of splicing are coordinated by
multiple splicing factors, andwe aimed to experimentally identify
examples of these. In the case of muscleblind-like 1 and 2,
we noted progressive downregulation of Mbnl1 and Mbnl2 at
each of the phases of reprogramming (Figure S2A). Mbnl1 and
Mbnl2 were previously shown to regulate AS programs that differ
between differentiated cells and pluripotent stem cells (Han
et al., 2013; Venables et al., 2013). In agreement with this, we
found that either Mbnl1/2 knockdown in MEFs or forced expres-
sion in ESCs induced reciprocal splicing changes in the Ssbp3,
Exoc1, Macf1, Tead1, and Mta1 transcripts consistent with
the changes observed during reprogramming (Figures 2B and
S2A). Interestingly, these Mbnl-regulated AS events represent
multiple temporal clusters (1, 2, and 4), which exhibit contrasting
temporal patterns of change (Figures 1B and 1C). Taken
together, our findings support previous studies indicating an
important role for Mbnl1/2 in regulation of splicing during reprog-
ramming and also suggest that the progressive downregulation
of these factors contributes to the changes in AS that occur
across the time course.
We sought to identify additional examples of select RBPs,
whose expression changes were observed in a phase-specific
manner, that may contribute to the AS patterns observed during
reprogramming. Two such examples are Zcchc24, which dis-
plays splicing activity in a reporter assay (R.P.C. and B.C., un-
published data) and is transcriptionally inactivated by day 4,
and Rbm47, a recently identified splicing factor that we noted
was upregulated specifically between day 20 and iPSCs (Van-
haranta et al., 2014; Figures 2C and 2D). We used RNAi-
mediated depletion in MEFs or ESC/iPSCs, respectively, and
screened a panel of early or late AS events by RT-PCR. This un-
covered three early events regulated by Zcchc24 and two late
events regulated by Rbm47 (Figures 2C, 2D, and S2B–S2D),
suggesting that these factors contribute to phase-specific pat-
terns of AS during reprogramming. Whereas these examples
demonstrate that this resource can be leveraged to identify novel
A B
C
Figure 1. Genome-wide Analysis of Alternative Splicing during Induced Pluripotency Reveals Distinct Phases of Regulation
(A) Experimental design and heatmap of genome-wide alternative splicing changes; blue and red represent decreased and increased PSI, respectively, relative to
the mean of each transcript across the time course.
(B) Examples of clusters with themedian PSI of three replicates at each time point of each exonwithin selected clusters are graphed in gray and themedian PSI for
the cluster in red.
(C) Radiolabeled RT-PCR validations of phase-specific AS during reprogramming as well as in ESCs (last lane).
For supplemental data, see also Figure S1.regulators of AS during reprogramming, future efforts will be
necessary to more comprehensively characterize the multifacto-
rial regulation of AS during induced pluripotency.
RBPs/splicing factors influence AS patterns by binding
to pre-mRNA in the introns flanking alternative exons or in
the exons themselves. Identifying enriched RBP-binding motifs
near alternative exons is a bioinformatic method that can impli-
cate specific factors in the regulation of splicing. We therefore
carried out motif enrichment analysis near alternative exons to
provide further insights into other splicing factors potentiallyinvolved in AS regulation during reprogramming. Examples of
known RBP-binding motifs enriched in the introns relative to
alternatively spliced exons were identified (Figure S3A). As
expected, Esrp1 (addressed in Figure 3)-binding sites were
enriched upstream and Mbnl1-binding sites were enriched
downstream of exons that undergo skipping during reprogram-
ming, respectively, consistent with the position-dependent RNA
maps for these splicing factors and their reciprocal expression
patterns during reprogramming (Dittmar et al., 2012; Han et al.,
2013). Interestingly, we identified two AS events that wereCell Reports 15, 247–255, April 12, 2016 249
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Figure 2. Complex Regulation of AS during Reprogramming Involving Multiple Splicing Factors
(A) Heatmap of gene expression changes of 95 RBPs selected based on the criteria described in the text. Examples of RBPs addressed in subsequent figures are
listed to the right.
(B) RT-PCR analysis of AS events that occur during reprogramming and are induced by Mbnl1/2 knockdown in MEFs (left column) or are reverted by ectopic
MBNL1 in V6.5 ESCs (right column and graph, which is the average PSI of biological duplicate with error bars representing SD from the mean [SDM]).
(C) RT-PCR analysis of AS events that occur by day 4 and are induced by two independent Zcchc24 small hairpin RNAs (shRNAs) in MEFs.
(D) RT-PCR analysis of AS events that change between day 20 and iPSC and are reverted by two independent siRNAs for Rbm47 in ESCs (for C and D, heatmaps
of RNA-seq data are shown [upper right] and RT-PCR [left] with quantitation of triplicate RT-PCRs in the graph and error bars representing SDM).
For supplemental data, see also Figures S2 and S3.antagonistically regulated by depletion of Mbnl1/2 or Esrp1 in
MEFs or ESCs, respectively (Figures S3B and S3C; Dittmar
et al., 2012; Han et al., 2013). Rbfox2 is involved in the regulation
of AS during ESC differentiation intomesoderm, and it is downre-
gulated as MEFs acquire pluripotency, with binding motifs en-
riched downstream of iPSC-silenced exons (Figure S3A; Table
S3).Also, thisanalysis identifiedenrichment for other splicing-fac-
tor-binding sites such as Ptbp1, Rbm24, and Rbm38. We also
mapped all enriched 6mers, which is likely to include the binding250 Cell Reports 15, 247–255, April 12, 2016sites of AS regulators forwhich the cognate-binding sites have yet
to be defined (Figure S3D). These motif enrichment data can
inform future studies aimed at further characterizing the multifac-
torial regulation of AS in reprogramming.
Previous studies identified induction of epithelial cell markers,
including Esrp1 and Esrp2, early during reprogramming consis-
tent with a MET phase (Li et al., 2010; Samavarchi-Tehrani
et al., 2010). Although our analysis for SE exon changes did
not reveal an obvious cluster that corresponded to this pattern,
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Figure 3. Esrp1 Regulates MET Phase AS and Enhances Reprogramming
(A) Heatmap of AS events that coincide with the expression changes in epithelial and mesenchymal marker genes during reprogramming.
(B) RT-PCR validation of MET-phase AS events that are reverted by Esrp1/2 knockout in ESCs.
(C) Quantitation of the PSI changes induced by Esrp1/2 KO in ESCs in biological duplicate; error bars are SDM.
(D) Enrichment for Esrp-binding motifs near exons regulated at theMET phase (day 7). Esrp-binding motif enrichment is seen upstream of day 7 alternative exons
that decrease in PSI (blue) and downstream of those that increase in PSI (red); the pre-mRNA is shown below with the alternative exon represented in green and
coordinates in base pairs (bps).
(E) Doxycycline-reprogrammable MEFs with an Oct4-NEO-Resistance allele were transduced with EGFP or Esrp1-emerald retroviral vectors and treated with
Dox (2 mg/ml) for 7 days followed by G418 selection for 1 week and then AP stain. Average colonies per well of five biological replicates with error bars repre-
senting SDM (above) and representative images of AP-positive colonies (below) are shown.
(F) Time course of Dox treatment prior to G418 selection for 1 week using the same MEF line as (E). Error bars are SDM of biological triplicate at each time point.
(G) AP-positive colonies that persisted after 10 days of Dox treatment followed by its removal and 10 days of Dox-free culture, conducted in biological triplicate.
For supplemental data, see Figures S3 and S4.
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E
Figure 4. Esrp1 Promotes Expression of a
Grhl1 Isoform that Enhances Reprogram-
ming
(A) RT-PCR analysis of Grhl1 exon 5 splicing
during reprogramming and effect of Esrp1 KO
in ESCs.
(B) Diagram of the full-length isoform of Grhl1
(Grhl1-FL) including the CP2 DNA-binding domain
in blue and the truncated/short isoform (Grhl1-S)
with exon 5 skipped and three out-of-frame amino
acids from exon 6 that precede the PTC depicted
in yellow.
(C) Dox-reprogrammable MEFs were transduced
with empty vector or Esrp1-FLAG and treated with
Dox for the indicated time followed by RNA isola-
tion and RT-PCR to assessGrhl1 exon 5 inclusion.
(D) Dox-reprogrammable MEFs were transduced
with EGFP, Grhl1-S, or Grhl1-FL and assayed
for AP-positive colonies after 10 days of Dox
treatment in biological quadruplicate; representa-
tive AP-positive colonies shown below; error bars
are SDM.
(E) Schematic of regulators of alternative splicing
during induced pluripotency.
For supplemental data, see Figure S4.we further examined the role of the Esrps in regulating splicing
primarily at the time period corresponding to MET based on
epithelial and mesenchymal marker expression (Figure 3A). We
validated seven splicing switches for a panel of alternative exons
that included previously defined Esrp-regulated events as well
as several that were identified using RNA-seq analysis of
Esrp1/Esrp2 double knockout ESCs (Figures 3B, 3C, and S3C;
Table S4; Dittmar et al., 2012; Warzecha et al., 2010). Binding
motif analysis near exons that change in splicing at day 7, where
Esrp1 expression is first observed, revealed enrichment for Esrp-
binding sites upstream of SEs and downstream of included
exons, consistent with our previously identified RNA map for
Esrp (Figure 3D). These data indicate that the upregulation of
Esrp1 and Esrp2 promotes AS changes during the MET phase
of reprogramming.
Enhancement of Reprogramming by Ectopic Esrp1
Inducing changes in AS through alterations in splicing factor
expression can impact reprogramming as shown in studies
where depletion ofMbnl1/2 enhanced reprogramming efficiency
(Han et al., 2013). Because the induction of MET was previously
shown to enhance reprogramming efficiency and Esrp1 is highly
upregulated during this phase, we hypothesized that ectopic
expression of Esrp1 in MEFsmight similarly enhance reprogram-
ming (Samavarchi-Tehrani et al., 2010; Li et al., 2010; Figure 3A).
To test this, we used MEFs from a transgenic mouse that is het-
erozygous for the Tet-OP-OKSM transgene that also harbors a
targeted Oct4-Neomycin-resistance (Oct4-NeoR) knockin allele252 Cell Reports 15, 247–255, April 12, 2016that allowed us to use G418 selection to
score reprogramming efficiency based
on activation of the endogenous Oct4
locus (Wernig et al., 2007). Ectopic
Esrp1 expression substantially enhancedreprogramming based upon the number of alkaline-phospha-
tase-positive colonies at day 10 of Dox induction (Figures S4A
and S4B) as well as the number of G418 resistant/alkaline
phosphatase (AP)-positive colonies and earlier acquisition of
G418 resistance (Figures 3E and 3F). The number of Dox-inde-
pendent, AP-positive colonies and Nanog-positive colonies
was also enhanced by Esrp1 (Figures 3G, S4C, and S4D). This
effect was not simply due to increased proliferation because
ectopic Esrp1 induced a modest but significant decrease in
the overall cell proliferation rate (Figure S4E).
One of the most-robust switches in AS from day 4 to 10 of
reprogramming (corresponding to an MET phase) is the acti-
vation of Esrp1-dependent exon 5 in the transcription factor
Grainyhead-like 1 (Grhl1) transcript. This exon was previously
identified as an Esrp-regulated event, and it showed skipping
after Esrp1 ablation in ESCs (Figure 4A; Table S4; Bebee et al.,
2015). This Esrp-regulated AS event is critical for the expression
of Grhl1 because skipping of this exon induces a frameshift
that results in a premature termination codon (PTC) upstream
of the CP2 DNA-binding domain, thereby producing a truncated
protein predicted to be functionally impaired as a transcription
factor (Figure 4B). Furthermore, the PTC would generate a pre-
dicted target for nonsense-mediated mRNA decay (NMD). We
noted that ectopic Esrp1 induced robust inclusion of Grhl1
exon 5 at 3 and 5 days after induction of reprogramming (Fig-
ure 4C). We therefore tested whether Grhl1 was a functionally
relevant Esrp1 target in the context of reprogramming. Indeed,
ectopic expression of the full-length isoform of Grhl1 enhanced
reprogramming whereas the shorter isoform did not (Figures 4D,
S4F, and S4G). Esrp-regulated splicing ofGrhl1 thus provides an
example of a functional link between AS and enhanced reprog-
ramming efficiency. Grhl1 is also activated at the level of tran-
scription during reprogramming (Table S3) and hence represents
an interesting example where transcriptional activation of a gene
needs to be coupled with AS in order to produce a functional
protein. However, there are almost surely other Esrp-regulated
splicing events that also functionally contribute to the ability of
Esrp1 to promote reprogramming. We also suspect that other
splicing factors whose expression is regulated during reprog-
ramming play key roles in the process, and the comprehensive
analysis of AS provided will serve to inform future investigations
to modulate splicing during reprogramming and cell differentia-
tion. A model for the complex regulation of AS in reprogramming
that is supported by our data is summarized in Figure 4E.
However, we note that this model is incomplete and the roles
of additional splicing factors and key regulated AS events require
further investigation.
DISCUSSION
Although previous studies have revealed regulated AS in plurip-
otent stem cells and in reprogramming, the work presented here
constitutes a detailed temporal analysis of AS during the acqui-
sition of pluripotency and implicates complex and phasic regula-
tion by different splicing factors.Many of these dynamic changes
in AS and splicing factor expression that we identified using our
network level analysis of temporal changes in splicing would
elude detection through analysis limited to differences between
somatic cells (including MEFs) and pluripotent stem cells. In
addition to the splicing factors characterized here, our data pro-
vide a tool that can be further leveraged to characterize other
splicing factors that are important for induced pluripotency as
well as differentiation into distinct cell lineages.
We determined that Esrp1 dramatically enhances and accel-
erates cellular reprogramming, an effect that can be attributed
in part to the AS regulation of Grhl1. However, the Esrps are not
required for maintenance of pluripotency, as we could maintain
Esrp1/Esrp2 double KO ESCs indefinitely without a loss of
pluripotent cell markers. This observation is similar to that for
Klf4, which promotes reprogramming yet is not required for plu-
ripotency based on analysis of the Klf4 KO phenotype (Segre
et al., 1999). Esrp1 is an example of a splicing factor that is
activated during reprogramming and can enhance efficiency,
an effect that is in contrast to that of the Mbnl1/2 splicing fac-
tors, which inhibit reprogramming. Our studies suggest that a
splicing switch in the transcription factor Grhl1 transcript is
one Esrp-regulated AS event during reprogramming that sup-
ports the acquisition of pluripotency. Few examples exist of
alternatively spliced genes that affect reprogramming in an
isoform-specific manner as we have shown for Grhl1. An addi-
tional example is Foxp1, where an ESC-specific isoform was
shown to alter DNA binding specificity toward pluripotency-
associated genes (Gabut et al., 2011). It will thus be of interest
to further investigate the transcriptional program influenced
by Grhl1 at the MET phase of reprogramming and in pluripotent
stem cells.Whereas we identified large-scale changes in splicing, further
studies are needed to characterize the functional impact of
these isoform switches at the protein level. Most AS events
remain poorly characterized in terms of their impact on protein
function and often require detailed case-by-case analysis. None-
theless, among the events with substantial changes in splicing
during reprogramming, we identified several cases where iso-
form-specific differences may be functionally related to cellular
reprogramming and pluripotency. The switch-like AS of tran-
scriptional co-regulators metastasis associated 1 (Mta1), TEA
domain family member 1 (Tead1), and nuclear transcription fac-
tor-Y alpha (Nfya) during reprogramming involves exons with
previously characterized roles in modulating the protein func-
tions by encoding a nuclear localization sequence (NLS), altering
DNA binding specificity and directing protein-protein interac-
tions with other transcription factors, respectively (Dolfini et al.,
2012; Jiang et al., 2000; Liang et al., 2008; Roder et al., 1999;
Yaguchi et al., 2005). However, there are surely changes in AS
during reprogramming and cell differentiation that generate
different protein isoforms that are functionally related to cell
fate decisions.
Our results highlight the complex and dynamic role that AS
plays in reprogramming and pluripotency and the need to
consider the combinatorial functions of numerous splicing fac-
tors in directing these cellular transitions. In addition to defining
temporal patterns of AS associated with acquisition of pluripo-
tency, these studies also provide a rationale and draft blueprint
for harnessing splicing factors to direct pluripotent cells down
defined lineages into distinct differentiated cell types useful for
regenerative medicine and disease modeling.
EXPERIMENTAL PROCEDURES
Mice and Primary Cells
Dox-inducible MEFs were isolated from embryos harboring a Col1a1-tetO-
OKSM and Rosa-26- rtTA (Stadtfeld et al., 2010). ESCs were from either
Esrp1flox/flox; Esrp2/ or Esrp1 wild-type; Esrp2/ mice or V6.5. All mouse
use was approved by the Institutional Animal Care and Use Committee
(IACUC) at the University of Pennsylvania.
Induction of Pluripotency
MEFs that were homozygous for the Col1a1-OKSM and Rosa26-rtTA alleles
were seeded onto gelatin-coated plates in ESC media and 2 mg/ml Dox for
the indicated time points. The cultures were passaged as needed and in the
presence of irradiated feeder MEFs from day 10 through iPSC. At each time
point, cultures were purified via Ssea1-MACS according to the manufacturer’s
protocol (Miltenyi Biotec), and the Ssea1-positive cells were then lysed in Trizol
reagent (Invitrogen) and stored at 80C. At day 20, Dox was removed and
clones that maintained an ESC-like morphology independent of transgene
expression for at least 2 weeks were mechanically isolated and expanded.
Retro and Lentiviral Transduction
For ectopic expression experiments, cDNAs were introduced into MEFs using
retroviral transduction as described previously (Warzecha et al., 2009).
shRNAs targeting Zcchc24 were introduced using the lentiviral vector
pLKO.1; packaging was conducted in 293T cells by transfecting 1 mg pLKO-
shRNA; 0.7 mg pSPAX2, and 0.3 mg cytomegalovirus (CMV)-vesicular stomati-
tis virus G protein (VSV-G) per well of a 6-well plate. MEFs were infected
overnight with a 1:5 ratio of viral supernatant to MEF media. AP staining was
carried out according to the manufacturer’s protocol (Vector Labs). Colonies
were imaged using the Typhoon fluorescence imager and quantified using
Image Quant colony counter tool.Cell Reports 15, 247–255, April 12, 2016 253
siRNA Transfection
MEFs were transfected with control, Mbnl1, and Mbnl2 siRNAs (Dharmacon
Smartpools; Han et al., 2013) using siRNA-Max transfection reagent (Life
Technologies) according to the manufacturer’s protocol. ESCs and iPSCs
were transfected with control and Rbm47 siRNAs (QIAGEN) also with
siRNA-Max after pre-plating feeder-depleted single-cell suspensions onto
gelatin-coated plates. Feeder MEFs were then added after 5 hr.
Computational Analysis of RNA-Seq Data
See Supplemental Experimental Procedures.
Statistical Methods
For RNA-seq analysis, we used Cuffdiff (v2.2.0) to calculate RNA-seq-based
gene expression levels using the FPKM metric and identified differential
gene expression between the two time points at FDR < 5% for a >2-fold differ-
ence in gene expression. To identify differential AS events between day 0 and
other time points, we used the statistical parameters of rMATS v3.0.8.
For the temporal cluster analysis of time course iPSC RNA-seq data, we
analyzed changes in RBP gene expression for significant changes in FPKM
across the seven time points (ANOVA p < 0.01). A similar approach was
used for AS changes at a Jackknife correlation coefficient threshold of 0.5
and a minimum of five exons per cluster (FDR = 0.02 based on permutation
test).
For motif enrichment analysis, we scanned for motif occurrences separately
in exons or their 250 base pairs upstream or downstream introns. For each
motif, after we counted the number of occurrences in the differentially spliced
exons and the control exons, we calculated the p value for enrichment via the
Fisher’s exact test (right-sided) and used Benjamini-Hochberg FDR correction
to adjust for multiple testing and identified enriched motifs at FDR < 5% and
p value < 0.01.
For additional details on statistical methods, see Supplemental Experi-
mental Procedures.
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